BenevolentAI

Feb 11, 2021

BenevolentAI announces first patient dosed in its Atopic Dermatitis clinical trial

Jan 27, 2021

BenevolentAI and AstraZeneca achieve collaboration milestone with novel AI-generated chronic kidney disease target

Nov 20, 2020

FDA grants Emergency Use Authorisation for baricitinib in hospitalised COVID-19 patients nine months after initial hypothesis was published by BenevolentAI

Sep 14, 2020

BenevolentAI's platform-derived hypothesis for COVID-19 treatment validated in US NIAID randomised control trial

Jun 18, 2020

Artificial Intelligence (AI) Sector is Leveraging Their Technology to Detect Outbreaks, Enable Effective Contact Tracing and Identify Existing Drugs to Treat COVID-19